Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | AHR | P35869 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.60 |
| ▸ | RAB9A | P51151 | 4/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | BACE1 | P56817 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27986152 | 0.98 | ALDH1A1 (0.63) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL6859623 | 0.98 | ALDH1A1 (0.63) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL30946935 | 0.98 | ALDH1A1 (0.63) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL17600557 | 0.98 | ALDH1A1 (0.63) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL30388558 | 0.98 | ALDH1A1 (0.63) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL710469 | 0.96 | ALDH1A1 (0.66) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL670646 | 0.92 | CYP1A2 (0.62) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL26456461 | 0.91 | ALDH1A1 (0.64) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL1088580 | 0.90 | CYP1A2 (0.69) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL24505927 | 0.89 | ALDH1A1 (0.59) | MAPTALDH1A1SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 412 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104269496-B | White organic light-emitting device and preparation method thereof | 中国科学院长春应用化学研究所 | 2017-04-19 | — | — | CN | claimed |
| CN-104269500-B | Red organic electroluminescent device and preparation method thereof | 中国科学院长春应用化学研究所 | 2017-04-12 | — | — | CN | claimed |
| CN-104393181-B | Red organic electroluminescent device and preparation method thereof | 中国科学院长春应用化学研究所 | 2017-02-01 | — | — | CN | claimed |
| CN-104270847-B | A kind of white color organic electroluminescence device and preparation method thereof | 中国科学院长春应用化学研究所 | 2016-09-28 | — | — | CN | claimed |
| CN-104393181-A | Red organic electroluminescent device and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2015-03-04 | — | — | CN | claimed |
| CN-104269496-A | White organic light-emitting device and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2015-01-07 | — | — | CN | claimed |
| CN-104270847-A | White organic light-emitting device and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2015-01-07 | — | — | CN | claimed |
| CN-104269500-A | Red organic electroluminescent device and preparation method thereof | CHANGCHUN APPLIED CHEMISTRY | 2015-01-07 | — | — | CN | claimed |
| US-20030100768-A1 | Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors | BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2003-05-29 | — | — | US | claimed |
| WO-2002048157-A2 | IMIDAZOLIDINONES AND THEIR RELATED DERIVATIVES AS HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2002-06-20 | — | — | WO | claimed |
| US-12641947-B2 | Organic light emitting diode and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-12637449-B2 | Organic compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-12635373-B2 | Organic light emitting diode and organic light emitting device including thereof | LG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12615910-B2 | Organic light emitting diode and organic light emitting device | LG DISPLAY CO., LTD. (KR) | 2026-04-28 | — | — | US | disclosed |
| US-12595257-B2 | Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device | LG DISPLAY CO., LTD. (KR) | 2026-04-07 | — | — | US | disclosed |
| US-4788204-A | TRANQUILIZERS; ANTICONVULSANTS; ANGINA AND IMMUNODIFICIENCY TREATMENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4788199-A | ANXIOLYTICS, ANTICONVULSANTS, ANTIANGINA AGENTS | RHONE-POULENC SANTE (FR) | 1988-11-29 | — | — | US | disclosed |
| US-4402961-A | Derivatives of 1-(2-,3- or 4-quinolyl)-2- or -3-(2- or 3-piperidyl or -pyrrolidinyl) ethanone or propanone, and their utilization as antiarrhythmics, anticonvulsivants and for the treatment of anxiety | PHARMINDUSTRIE (FR) | 1983-09-06 | — | — | US | disclosed |
| US-4316621-A | Pressure-sensitive or heat-sensitive recording material | CIBA-GEIGY CORPORATION (US) | 1982-02-23 | — | — | US | disclosed |
| EP-0027913-A2 | Pressure-sensitive or heat-sensitive recording material | CIBA-GEIGY AG (CH) | 1981-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12641947-B2 | Organic light emitting diode and organic light emitting device including the same | CRY1, OR10J3, CRY2 | MAPT 2899/4885ALDH1A1 69/4885SMN1; SMN2 4084/4885 |
| US-12635373-B2 | Organic light emitting diode and organic light emitting device including thereof | CTNND1, OPRD1, CRY2 | MAPT 2252/4885ALDH1A1 1014/4885SMN1; SMN2 4361/4885 |
| US-12595257-B2 | Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device | C1R, CBR1, HCRTR2 | MAPT 4490/4885ALDH1A1 2152/4885SMN1; SMN2 3049/4885 |
| US-20030100768-A1 | Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors | PRSS1, SPINT2, SERPINB1 | MAPT 4048/4885ALDH1A1 700/4885SMN1; SMN2 4044/4885 |
| US-12637449-B2 | Organic compound and organic light emitting device including the same | CRY1, NR2E3, CRY2 | MAPT 3383/4885ALDH1A1 289/4885SMN1; SMN2 3211/4885 |
| US-12615910-B2 | Organic light emitting diode and organic light emitting device | OR10J3, OCIAD2, CTNND1 | MAPT 623/4885ALDH1A1 176/4885SMN1; SMN2 3065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.